Annual Current Liabilities
$11.62 M
+$3.26 M+39.04%
December 31, 2023
Summary
- As of February 12, 2025, AVBP annual total current liabilities is $11.62 million, with the most recent change of +$3.26 million (+39.04%) on December 31, 2023.
- During the last 3 years, AVBP annual current liabilities has risen by +$9.81 million (+539.38%).
- AVBP annual current liabilities is now at all-time high.
Performance
AVBP Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$11.62 M
-$474.00 K-3.92%
September 1, 2024
Summary
- As of February 12, 2025, AVBP quarterly total current liabilities is $11.62 million, with the most recent change of -$474.00 thousand (-3.92%) on September 1, 2024.
- Over the past year, AVBP quarterly current liabilities has dropped by -$474.00 thousand (-3.92%).
- AVBP quarterly current liabilities is now -9.28% below its all-time high of $12.81 million, reached on June 1, 2023.
Performance
AVBP Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
AVBP Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +39.0% | -3.9% |
| 3 y3 years | +539.4% | -3.9% |
| 5 y5 years | +539.4% | -3.9% |
AVBP Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +539.4% | -9.3% | +39.0% |
| 5 y | 5-year | at high | +539.4% | -9.3% | +39.0% |
| alltime | all time | at high | +539.4% | -9.3% | +39.0% |
ArriVent BioPharma Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $11.62 M(-3.9%) |
| Jun 2024 | - | $12.10 M(+21.3%) |
| Mar 2024 | - | $9.98 M(-14.2%) |
| Dec 2023 | $11.62 M | $11.62 M(+15.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $10.10 M(-21.2%) |
| Jun 2023 | - | $12.81 M(+53.3%) |
| Dec 2022 | $8.36 M(+359.8%) | - |
| Dec 2022 | - | $8.36 M |
| Dec 2021 | $1.82 M | - |
FAQ
- What is ArriVent BioPharma annual total current liabilities?
- What is the all time high annual current liabilities for ArriVent BioPharma?
- What is ArriVent BioPharma annual current liabilities year-on-year change?
- What is ArriVent BioPharma quarterly total current liabilities?
- What is the all time high quarterly current liabilities for ArriVent BioPharma?
- What is ArriVent BioPharma quarterly current liabilities year-on-year change?
What is ArriVent BioPharma annual total current liabilities?
The current annual current liabilities of AVBP is $11.62 M
What is the all time high annual current liabilities for ArriVent BioPharma?
ArriVent BioPharma all-time high annual total current liabilities is $11.62 M
What is ArriVent BioPharma annual current liabilities year-on-year change?
Over the past year, AVBP annual total current liabilities has changed by +$3.26 M (+39.04%)
What is ArriVent BioPharma quarterly total current liabilities?
The current quarterly current liabilities of AVBP is $11.62 M
What is the all time high quarterly current liabilities for ArriVent BioPharma?
ArriVent BioPharma all-time high quarterly total current liabilities is $12.81 M
What is ArriVent BioPharma quarterly current liabilities year-on-year change?
Over the past year, AVBP quarterly total current liabilities has changed by -$474.00 K (-3.92%)